Arcus Biosciences
RCUS
RCUS
148 hedge funds and large institutions have $1.25B invested in Arcus Biosciences in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 53 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
–
Holders Change %
0%
% of All Funds
2.61%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
25
Increased
51
Reduced
53
Closed
24
Calls
$3.19M
Puts
$13.1M
Net Calls
-$9.92M
Net Calls Change
-$12.5M
Top Buyers
| 1 |
WP
Woodline Partners
San Francisco,
California
|
+$34.8M |
| 2 |
HM
HealthCor Management
New York
|
+$15.1M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$11.2M |
| 4 |
State Street
Boston,
Massachusetts
|
+$9.62M |
| 5 |
Renaissance Technologies
New York
|
+$7.21M |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$24.6M |
| 2 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$16.1M |
| 3 |
Alkeon Capital Management
New York
|
-$10.6M |
| 4 |
CCM
Consonance Capital Management
New York
|
-$10.1M |
| 5 |
AI
Alphabet Inc
Mountain View,
California
|
-$9.17M |
